272: Vivek's star turn, leaky drug data, & biotech as family business

Discussion on the rise of a biotech entrepreneur turned presidential candidate. Coverage of his debate performance and reactions from former biotech colleagues. Mention of a data leak and the family business of a renowned biotech inventor. Focus on the leaked slide revealing data on Tidget drugs and challenges in immuno-oncology. Exploring the fundraising efforts of biotech firm T dot RX and the close relationships between biotech entrepreneurs and certain funding firms.